Hutchmed unveils new CEO as longtime CSO takes the reins ahead of first U.S. drug launchnews2022-03-04T16:10:20+00:00March 4th, 2022|Fierce Pharma|
Hutchmed unveils new CEO as longtime CSO takes the reins ahead of first US drug launchnews2022-03-04T16:10:20+00:00March 4th, 2022|Fierce Pharma|
GlaxoSmtihKline rewards CEO Walmsley with a 17% pay bump, to £8.2 millionnews2022-03-04T14:56:39+00:00March 4th, 2022|Fierce Pharma|
GlaxoSmithKline rewards CEO Walmsley with a 17% pay bump, to £8.2 millionnews2022-03-04T14:56:39+00:00March 4th, 2022|Fierce Pharma|
Amgen’s Xgeva campaign features real patients talking about their lives after diagnosisnews2022-03-04T14:36:36+00:00March 4th, 2022|Fierce Pharma|
Amgen’s Xgeva campaign features real cancer patients talking about their lives after diagnosisnews2022-03-04T14:36:36+00:00March 4th, 2022|Fierce Pharma|
Pfizer recalls 2nd blood pressure med in a week, again on potential carcinogen fearsnews2022-03-04T14:07:45+00:00March 4th, 2022|Fierce Pharma|
Eli Lilly extends winning streak as it keeps the TV ad spend throne holding off Regeneron’s Dupixentnews2022-03-04T12:48:03+00:00March 4th, 2022|Fierce Pharma|
Eli Lilly extends winning streak as it keeps the TV ad spend throne, holding off Sanofi and Regeneron’s Dupixentnews2022-03-04T12:48:03+00:00March 4th, 2022|Fierce Pharma|
Fierce Pharma Asia—J&J, Legend’s CAR-T nod; Biocon’s $3.3B Viatris biosimilar buy; Sanofi-Adagene tie-upnews2022-03-04T10:16:33+00:00March 4th, 2022|Fierce Pharma|
